Gyre Therapeutics

7.96
+0.81
+11.33%
GYRE
 8.50 7.75 33.12万股总市值 7.67亿
 7.75 0.34% 268.60万市盈TTM 184.07
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
Gyre Therapeutics(GYRE)
09-10 21:05  
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-034506  Act: 34  Size: 4 MB 网页链接
用户头像
Gyre Therapeutics(GYRE)
08-27 04:15  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-032719  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
08-27 04:05  
$Gyre Therapeutics(GYRE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001140361-25-032710  Size: 11 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
08-22 19:15  
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001140361-25-032295  Act: 34  Size: 185 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
08-12 05:15  
$Gyre Therapeutics(GYRE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-106644  Act: 34  Size: 15 MB 网页链接
用户头像
Gyre Therapeutics(GYRE)
08-12 04:05  
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 2.02, 5.02, 7.01, and 9.01 Accession Number: 0000950170-25-106525  Act: 34  Size: 681 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
08-08 08:05  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-029693  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
06-07 04:25  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021789  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
06-07 04:25  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021793  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
06-07 04:25  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021792  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
06-07 04:25  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021791  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
06-07 04:25  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-021790  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
06-06 18:05  
$Gyre Therapeutics(GYRE)$ 8-K Current report, item 5.07 Accession Number: 0001140361-25-021612  Act: 34  Size: 169 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
05-30 04:05  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020754  Size: 7 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
05-29 06:15  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020669  Size: 5 KB 网页链接
用户头像
Gyre Therapeutics(GYRE)
05-28 04:05  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020474  Size: 7 KB 网页链接
1
用户头像
Gyre Therapeutics(GYRE)
05-24 04:55  
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001140361-25-020353  Act: 34  Size: 741 KB 网页链接
1
用户头像
Gyre Therapeutics(GYRE)
05-24 04:45  
$Gyre Therapeutics(GYRE)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001140361-25-020349  Act: 33  Size: 701 KB 网页链接
1
用户头像
Gyre Therapeutics(GYRE)
05-23 05:35  
$Gyre Therapeutics(GYRE)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001140361-25-020208  Act: 33  Size: 702 KB 网页链接
1
用户头像
Gyre Therapeutics(GYRE)
05-23 04:05  
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-020156  Size: 7 KB 网页链接
1